These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2997067)

  • 1. Platelet-dependent granulocyte activation in vitro: effect of ticlopidine.
    Laghi Pasini F; Ceccatelli L; Pasqui AL; Orrico A; Capecchi PL; Di Perri T
    Int J Tissue React; 1985; 7(5):367-72. PubMed ID: 2997067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.
    Di Minno G; Cerbone AM; Mattioli PL; Turco S; Iovine C; Mancini M
    J Clin Invest; 1985 Feb; 75(2):328-38. PubMed ID: 3156146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
    Porta C; Maiolo A; Tua A; Grignani G
    Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activation induced by a human neuroblastoma tumor cell line is reduced by prior administration of ticlopidine.
    Bastida E; Escolar G; Almirall L; Ordinas A
    Thromb Haemost; 1986 Jun; 55(3):333-7. PubMed ID: 3750263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet modulation of neutrophil superoxide anion production.
    Moon DG; van der Zee H; Weston LK; Gudewicz PW; Fenton JW; Kaplan JE
    Thromb Haemost; 1990 Feb; 63(1):91-6. PubMed ID: 2160133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of cytochalasin B on platelet release, aggregation and contractility: evidence against a contractile mechanism for the release of platelet granular contents.
    Kirkpatrick JP; McIntire LV; Moake JL; Cimo PL
    Thromb Haemost; 1980 Feb; 42(5):1483-9. PubMed ID: 6892735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interaction of adenosine with leukocytes and thrombocytes].
    Becker BF; Zahler S; Seligmann C; Kupatt C; Habazettl H
    Z Kardiol; 1996; 85 Suppl 6():161-70. PubMed ID: 9064961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro effect of ticlopidine on fibrinogen and factor VIII binding to human platelets.
    Lee H; Paton RC; Ruan C; Caen JP
    Thromb Haemost; 1981 Oct; 46(3):590-2. PubMed ID: 6797089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets.
    Koda M; Banno Y; Naganawa T
    Platelets; 2005 Dec; 16(8):482-91. PubMed ID: 16287615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the beta-blocker therapy on neutrophil superoxide generation and platelet aggregation in experimental myocardial ischemia and reflow.
    Röth E; Matos G; Guarnieri C; Papp B; Varga J
    Acta Physiol Hung; 1995; 83(2):163-70. PubMed ID: 8588503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ticlopidine of platelet function in men with stable angina pectoris.
    Berglund U; von Schenck H; Wallentin L
    Thromb Haemost; 1985 Dec; 54(4):808-12. PubMed ID: 3911481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases.
    Evangelista V; Rajtar G; de Gaetano G; White JG; Cerletti C
    Blood; 1991 Jun; 77(11):2379-88. PubMed ID: 1645603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet, antineutrophil and vasodilating properties of 13,14-dihydro-PGE1 (PGE0)--an in vivo metabolite of PGE1 in man.
    Ney P; Braun M; Szymanski C; Bruch L; Schrör K
    Eicosanoids; 1991; 4(3):177-84. PubMed ID: 1663381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine diphosphate (ADP)-induced alpha-granules release from platelets of native whole blood is reduced by ticlopidine but not by aspirin or dipyridamole.
    Pengo V; Boschello M; Marzari A; Baca M; Schivazappa L; Dalla Volta S
    Thromb Haemost; 1986 Oct; 56(2):147-50. PubMed ID: 3810554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human blood platelets, PMN leukocytes and their interactions in vitro. Responses to selective and non-selective stimuli.
    Drábiková K; Jancinová V; Nosál R; Danihelová E
    Gen Physiol Biophys; 2000 Dec; 19(4):393-404. PubMed ID: 11409842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).
    Shaw JO; Pinckard RN; Ferrigni KS; McManus LM; Hanahan DJ
    J Immunol; 1981 Sep; 127(3):1250-5. PubMed ID: 6267133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on fibronectin and its domains. I. Novel recombinant cell-binding domain of fibronectin--a modulator of human platelet functions.
    Vogel T; Werber MM; Guy R; Levanon A; Nimrod A; Legrand C; Gorecki M; Eldor A; Panet A
    Arch Biochem Biophys; 1993 Jan; 300(1):501-9. PubMed ID: 8424687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human endothelial cells inhibit granulocyte aggregation in vitro.
    Zimmerman GA; Klein-Knoeckel D
    J Immunol; 1986 May; 136(10):3839-47. PubMed ID: 3009611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clopidogrel inhibits platelet-leukocyte adhesion and platelet-dependent leukocyte activation.
    Evangelista V; Manarini S; Dell'Elba G; Martelli N; Napoleone E; Di Santo A; Lorenzet PS
    Thromb Haemost; 2005 Sep; 94(3):568-77. PubMed ID: 16268474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.